CAR T-Cell Therapy Advances: Remote-Control Systems and Glioblastoma Applications
Researchers have developed a remote-controlled CAR T-cell therapy that can be switched off on demand using venetoclax, while new engineering strategies aim to overcome barriers in treating glioblastoma and other solid tumors.